Macular oedema treatment to be available on PBS


macular degeneration - closeup on eye with lots of high tech crosshairs

A government subsidy for a biologic to treat vision impairment caused by macular oedema in patients with diabetes or retinal vein occlusion (branch or central) will be available from 1 July.



This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Register here

Forgot Password?Why do I need to login & stay in?

Previous CMA calls for less health red tape, more innovation support
Next Don't mandate country of origin labelling: ASMI

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply